Allele Capital Partners

Allele Capital Partners is a merchant bank based in Lauderdale, Florida, established in 2017. The firm specializes in providing venture capital and private equity financing to private and small-cap public companies within the healthcare and life sciences sectors. Allele partners with clients to deliver a range of services, including strategic advisory, capital raising, and transaction execution. Their offerings encompass various financing options such as mezzanine financing, alternative public offerings, initial public offerings, private placements, and secondary offerings. Additionally, Allele provides advisory services that include capital markets access, fairness opinions, and corporate services, facilitating comprehensive support for their clients' financial needs.

Ankit Bhargava

Managing Director

Brian Debeer

Analyst

Matt Hughes

Managing Partner

George Kogan

Managing Director

Menachem Kranz

Co-Founder and Partner

Tom Masterson

Managing Director

Shawn Titcomb

Investor

Harshawardhan Bal Ph.D

Managing Director

1 past transactions

Coya Therapeutics

Series A in 2021
Coya Therapeutics is a clinical-stage biotechnology company developing first-in-class and best-in-class approaches utilizing adoptive regulatory T cells (Tregs) to target disease. The company’s proprietary CTreg (cryopreservation for Tregs) system is the first in the industry to create an ‘off the shelf’ approach to Treg cell therapy allowing for serial infusions. Through our patented TAI™ (Tregs Against Inflammation) and EAITM (Exosomes Against Inflammation) platforms, Coya is focused on the advancement of disease modifying approaches to address the significant unmet medical needs of patients with ALS, Parkinson’s, Alzheimer’s, FTD and autoimmune diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.